These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 8390705)

  • 1. [Splenic embolization and hepatic chemoembolization: combined transcatheter treatment of hepatocellular carcinoma in cirrhosis with hypersplenism].
    Roversi R; Ricci S; Gambari PI; Castaldini L; Rossi G; Milandri G; Formica G; Dalmonte PR
    Radiol Med; 1993 Apr; 85(4):444-9. PubMed ID: 8390705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on primary hepatocellular carcinoma associated with hypersplenism treated by partial splenic embolization combined with hepatic arterial chemoembolization].
    Huang JH; Wu PH; Gu YK; Zhang FJ; Li CX; Gao F; Zhang L; Fan WJ; Li CJ
    Ai Zheng; 2006 Aug; 25(8):1003-6. PubMed ID: 16965683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The significance of combined treatment for hepatocellular carcinoma with partial splenic embolization and transcatheter arterial chemoembolization using IA call/lipiodol].
    Harao M; Beppu T; Masuda T; Hayashi H; Okabe H; Okabe K; Imseung C; Komori H; Horino K; Baba H
    Gan To Kagaku Ryoho; 2008 Nov; 35(12):2027-9. PubMed ID: 19106512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcatheter partial splenic arterial embolization in patients with hypersplenism: a clinical evaluation as supporting therapy for hepatocellular carcinoma and liver cirrhosis.
    Hirai K; Kawazoe Y; Yamashita K; Kumagai M; Tanaka M; Sakai T; Inoue R; Eguchi S; Majima Y; Abe M
    Hepatogastroenterology; 1986 Jun; 33(3):105-8. PubMed ID: 3017829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of chemoembolization with conventional chemotherapy and symptomatic treatment in cirrhotic patients with hepatocellular carcinoma.
    Bayraktar Y; Balkanci F; Kayhan B; Uzunalimoglu B; Gokoz A; Ozisik Y; Gurakar A; Van Thiel DH; Firat D
    Hepatogastroenterology; 1996; 43(9):681-7. PubMed ID: 8799415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous treatment of hepatocellular carcinoma in patients with transjugular intrahepatic portosystemic shunts.
    Tesdal IK; Wikström M; Flechtenmacher C; Filser T; Dueber C
    Cardiovasc Intervent Radiol; 2006; 29(5):778-84. PubMed ID: 16779690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laparoscopic splenectomy may be a superior supportive intervention for cirrhotic patients with hypersplenism.
    Tomikawa M; Akahoshi T; Sugimachi K; Ikeda Y; Yoshida K; Tanabe Y; Kawanaka H; Takenaka K; Hashizume M; Maehara Y
    J Gastroenterol Hepatol; 2010 Feb; 25(2):397-402. PubMed ID: 19929930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Transarterial embolization in the treatment of hepatoma complicated with cirrhosis, esophageal varices and hypersplenism].
    Tsuji Y; Nishimura A; Yasuda T; Katsuki Y
    Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2520-4. PubMed ID: 2843116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial splenic embolization for hypersplenism concomitant with or after arterial embolization of hepatocellular carcinoma in 30 patients.
    Han MJ; Zhao HG; Ren K; Zhao DC; Xu K; Zhang XT
    Cardiovasc Intervent Radiol; 1997; 20(2):125-7. PubMed ID: 9030503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The safety and efficacy of transcatheter arterial chemoembolization in the treatment of patients with hepatocellular carcinoma and main portal vein obstruction. A prospective controlled study.
    Lee HS; Kim JS; Choi IJ; Chung JW; Park JH; Kim CY
    Cancer; 1997 Jun; 79(11):2087-94. PubMed ID: 9179054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long-term results of interventional treatment of large unresectable hepatocellular carcinoma (HCC): significant survival benefit from combined transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) compared to TACE monotherapy].
    Lubienski A; Bitsch RG; Schemmer P; Grenacher L; Düx M; Kauffmann GW
    Rofo; 2004 Dec; 176(12):1794-802. PubMed ID: 15573291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial splenic embolization for hypersplenism in cirrhosis: a long-term outcome in 62 patients.
    Zhu K; Meng X; Qian J; Huang M; Li Z; Guan S; Jiang Z; Shan H
    Dig Liver Dis; 2009 Jun; 41(6):411-6. PubMed ID: 19070555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of partial splenic embolization (PSE) on liver function test in patients with liver cirrhosis].
    Nomiyama K; Akagi K; Watanabe H; Kajiwara E; Sakino I
    Fukuoka Igaku Zasshi; 1991 Mar; 82(3):105-9. PubMed ID: 2066049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes of transcatheter arterial chemoembolization with autologous blood clot for unresectable hepatocellular carcinoma.
    Gunji T; Kawauchi N; Akahane M; Watanabe K; Kanamori H; Ohnishi S
    Int J Oncol; 2002 Aug; 21(2):427-32. PubMed ID: 12118341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of partial splenic embolization on transarterial chemoembolization for hepatocellular carcinoma with hypersplenism.
    Liu J; Wu Z; Zhang J; Xie Y; Sun P; Wu H; Chang X; Zhang L; Liu F
    Medicine (Baltimore); 2021 Jul; 100(26):e26441. PubMed ID: 34190168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Factors related to acute upper gastrointestinal bleeding after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma].
    Wu JX; Huang JF; Yu ZJ; Meng XY; Li DG; Lu HM
    Ai Zheng; 2002 Aug; 21(8):881-4. PubMed ID: 12478898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative transcatheter arterial chemoembolization reduces long-term survival rate after hepatic resection for resectable hepatocellular carcinoma.
    Sasaki A; Iwashita Y; Shibata K; Ohta M; Kitano S; Mori M
    Eur J Surg Oncol; 2006 Sep; 32(7):773-9. PubMed ID: 16797156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergency embolization in the treatment of ruptured hepatocellular carcinoma following transcatheter arterial chemoembolization.
    Sun JH; Wang LG; Bao HW; Lou JL; Cai LX; Wu C; Chen LM; Zheng SS
    Hepatogastroenterology; 2010; 57(99-100):616-9. PubMed ID: 20698237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer.
    Marelli L; Shusang V; Buscombe JR; Cholongitas E; Stigliano R; Davies N; Tibballs J; Patch D; Meyer T; Burroughs AK
    J Nucl Med; 2009 Jun; 50(6):871-7. PubMed ID: 19443599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoembolization in patients at high risk: results and complications.
    Kiely JM; Rilling WS; Touzios JG; Hieb RA; Franco J; Saeian K; Quebbeman EJ; Pitt HA
    J Vasc Interv Radiol; 2006 Jan; 17(1):47-53. PubMed ID: 16415132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.